Prospective Study
Copyright ©The Author(s) 2025.
World J Clin Oncol. Feb 24, 2025; 16(2): 97107
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.97107
Table 1 Demographic and clinical factor recorded
Demographic
Clinical
AgeSmoking
SexEthanol
Working statusNumber of medications
Family history of CRC
Personal history of CRC
Years since diagnosis
Table 2 Clinical and demographic characteristics of cohort

n (%)
Sex
    Male15 (29.41)
    Female36 (70.59)
Age at SPS diagnosis (years), mean48.14
    SD10.88
    Range23-62
Family history of CRC
    1st degree15 (29.41)
    2nd degree9 (17.65)
    No23 (45.10)
    Unknown2 (3.92)
    Missing data2 (3.92)
Previous history of CRC
    CRC prior to Dx of SPS1 (1.96)
    CRC at time of SPS Dx0 (0)
    CRC post SPS Dx0 (0)
    No CRC48 (94.12)
    Missing data2 (3.92)
Smoking status
    Yes4 (7.84)
    No36 (70.59)
    Ex-smoker9 (17.65)
    Missing data2 (3.92)
Ethanol intake (> 30 gm per day)
    Yes7 (13.73)
    No42 (82.35)
    Missing data2 (3.92)
Employment status
    Full-time33 (64.71)
    Part-time12 (23.53)
    Casual4 (7.84)
    Not working2 (3.92)
Table 3 Health anxiety score distribution

Mean (SD), range
Total sample13.43 (6.16), 2-30
Sex
    Male13.87 (5.55), 7-25
    Female13.25 (6.46), 2-30
Age
    < 45 years12.17 (8.04), 5-30
    ≥ 45 years13.82 (5.12), 2-25
Health anxiety (%)
    Score ≥ 18n = 11 (21.57)
    Score ≥ 30n = 1 (1.96)
Table 4 Attitudes towards personalised surveillance of serrated polyposis syndrome patients, with or without health anxiety

Health anxiety
No health anxiety
P value
95%CI
Odds ratio
Personalised surveillance0.00190912.42-34.197.60
    Not worried230
    Slightly worried69
    Worried31
    Very worried00